4880 CellSource
- 1250
- -55-4.21%
CellSource News
CellSource: [Summary]Non-consolidated Financial Results for the Nine Months Ended July 31, 2024 (Under Japanese GAAP)
CellSource: Earnings Presentation Q3 FY10/2024
CellSource: Presentation of financial results for the 3rd quarter of the fiscal year ending 2024/10
CellSource: Summary of financial results for the 3rd quarter of the fiscal year ending 2024/10 [Japanese GAAP] (unconsolidated)
CellSource: CellSource Advances Processing Technology for Contract Processing Services of Adipose-Derived Stem Cells
CellSource: Notice Regarding Acquisition of Medibase as a Wholly Owned Subsidiary Through Share Purchase
CellSource: Notice Concerning Revisions to Full-Year Financial Results Forecasts
CellSource: Cell Source Adipose-Derived Stem Cell Processing Contract Service Technology Update Notice
CellSource: Notice regarding the acquisition of shares in Medibase Co., Ltd. and making it a wholly owned subsidiary
CellSource: Notice regarding revisions to earnings forecasts
CellSource: CellSource's egg freezing safety bank service has been adopted into FamilyMart's employee welfare system.
CellSource: FamilyMart has introduced Cell Source's Egg Freezing Assurance Bank as a welfare program.
CellSource: CellSource has signed a contract to operate the online briefing for the egg freezing program in Tokyo.
CellSource: Cell source has been entrusted with the operation of an online briefing for individuals affected by the egg freezing in Tokyo.
CellSource: CellSource's egg freezing service, Anshin Bank, has been adopted by Unicharm's employee welfare program.
CellSource: The Cell source "Safe Egg Freezing Bank" has been introduced as a benefit system at Uni-Charm.
CellSource: [Postponed] Earnings conference for the second quarter of the October 2024 fiscal year.
CellSource: Confirmation letter
CellSource: Quarterly Report - 2nd Quarter of the 9th period (February 1, 2024 - April 30, 2024)
CellSource: Financial results presentation materials for the second quarter of fiscal year ending October 2024.
Analysis
Price Target
No Data
No Data